Lotze MT - Search Results

1

Acute immunologic effects of interleukin-2 therapy in cancer patients: decreased delayed type hypersensitivity response and decreased proliferative response to soluble antigens.

Wiebke EA, Rosenberg SA, Lotze MT. Wiebke EA, et al. Among authors: lotze mt. J Clin Oncol. 1988 Sep;6(9):1440-9. doi: 10.1200/JCO.1988.6.9.1440. J Clin Oncol. 1988. PMID: 3262151

2

Intravenous administration of recombinant human macrophage colony-stimulating factor to patients with metastatic cancer: a phase I study.

Sanda MG, Yang JC, Topalian SL, Groves ES, Childs A, Belfort R Jr, de Smet MD, Schwartzentruber DJ, White DE, Lotze MT, et al. Sanda MG, et al. Among authors: lotze mt. J Clin Oncol. 1992 Oct;10(10):1643-9. doi: 10.1200/JCO.1992.10.10.1643. J Clin Oncol. 1992. PMID: 1403042 Clinical Trial.

3

HLA association with response and toxicity in melanoma patients treated with interleukin 2-based immunotherapy.

Marincola FM, Venzon D, White D, Rubin JT, Lotze MT, Simonis TB, Balkissoon J, Rosenberg SA, Parkinson DR. Marincola FM, et al. Among authors: lotze mt. Cancer Res. 1992 Dec 1;52(23):6561-6. Cancer Res. 1992. PMID: 1423301

4

A pilot study of the combination of interleukin-2-based immunotherapy and radiation therapy.

Lange JR, Raubitschek AA, Pockaj BA, Spencer WF, Lotze MT, Topalian SL, Yang JC, Rosenberg SA. Lange JR, et al. Among authors: lotze mt. J Immunother (1991). 1992 Nov;12(4):265-71. doi: 10.1097/00002371-199211000-00007. J Immunother (1991). 1992. PMID: 1477077 Clinical Trial.

5

Delayed reactions to contrast media after interleukin-2 immunotherapy.

Choyke PL, Miller DL, Lotze MT, Whiteis JM, Ebbitt B, Rosenberg SA. Choyke PL, et al. Among authors: lotze mt. Radiology. 1992 Apr;183(1):111-4. doi: 10.1148/radiology.183.1.1549655. Radiology. 1992. PMID: 1549655

6

Cytokine regulation of tumor necrosis factor-alpha and -beta (lymphotoxin)-messenger RNA expression in human peripheral blood mononuclear cells.

Kasid A, Director EP, Stovroff MC, Lotze MT, Rosenberg SA. Kasid A, et al. Among authors: lotze mt. Cancer Res. 1990 Aug 15;50(16):5072-6. Cancer Res. 1990. PMID: 1696166

7

Lymphocytes as cellular vehicles for gene therapy in mouse and man.

Culver K, Cornetta K, Morgan R, Morecki S, Aebersold P, Kasid A, Lotze M, Rosenberg SA, Anderson WF, Blaese RM. Culver K, et al. Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3155-9. doi: 10.1073/pnas.88.8.3155. Proc Natl Acad Sci U S A. 1991. PMID: 2014235 Free PMC article.

8

Lysis of autologous melanoma cells by tumor-infiltrating lymphocytes: association with clinical response.

Aebersold P, Hyatt C, Johnson S, Hines K, Korcak L, Sanders M, Lotze M, Topalian S, Yang J, Rosenberg SA. Aebersold P, et al. J Natl Cancer Inst. 1991 Jul 3;83(13):932-7. doi: 10.1093/jnci/83.13.932. J Natl Cancer Inst. 1991. PMID: 2067036 Clinical Trial.

9

Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.

Wiebke EA, Custer MC, Rosenberg SA, Lotze MT. Wiebke EA, et al. Among authors: lotze mt. J Biol Response Mod. 1990 Apr;9(2):113-26. J Biol Response Mod. 1990. PMID: 2111373

10

IL-2-based immunotherapy alters circulating neutrophil Fc receptor expression and chemotaxis.

Jablons D, Bolton E, Mertins S, Rubin M, Pizzo P, Rosenberg SA, Lotze MT. Jablons D, et al. Among authors: lotze mt. J Immunol. 1990 May 1;144(9):3630-6. J Immunol. 1990. PMID: 2158514

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

572 results

Search Page

Filters